Prot#AZD4831 - D6580C00003: A Randomized, Blinded, Placebo-Controlled, Parallel Group, Multicentre Study to Assess Safety and Tolerability of AZD4831 in Patiens with Heart Failure with Preserved Ejection Fraction, HFpEF

Project: Research project

Project Details

StatusFinished
Effective start/end date4/12/19 → 4/12/22

Funding

  • DrugDev Inc. (Prot#AZD4831 - D6580C00003 // Prot#AZD4831 - D6580C00003)
  • AstraZeneca Pharmaceuticals LP (Prot#AZD4831 - D6580C00003 // Prot#AZD4831 - D6580C00003)